Related Experiment Video
Updated: Aug 5, 2026

06:19
Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
Real-World Safety of Intravitreal Complement Inhibitor Avacincaptad Pegol for Geographic Atrophy
Alexander Shaer1, Tadashi Yokoi1,2, Eshani Ragam1
1Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Journal of Vitreoretinal Diseases
|July 28, 2026
Summary
Intravitreal avacincaptad pegol demonstrates a favorable safety profile for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This real-world study found low rates of adverse events, including inflammation and neovascular AMD conversion.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a leading cause of irreversible vision loss.
- Intravitreal (IVT) therapies are crucial for managing AMD, but their real-world safety profiles require ongoing evaluation.
- Avacincaptad pegol is an investigational drug targeting GA, necessitating comprehensive safety data.
Purpose of the Study:
- To assess the real-world ocular safety of intravitreal avacincaptad pegol in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
- To evaluate the incidence of adverse events, including intraocular inflammation, endophthalmitis, ocular hypertension, and conversion to neovascular AMD (nAMD).
- To provide data for patient counseling and monitoring strategies related to avacincaptad pegol treatment.
Main Methods:
- Retrospective analysis of 845 eyes from 590 patients treated with intravitreal avacincaptad pegol for GA.
- Inclusion of eyes with concurrent neovascular AMD (nAMD) and assessment of conversion (new-onset nAMD) and reactivation rates.
- Evaluation of demographics, treatment characteristics, visual acuity (VA), intraocular pressure (IOP), and adverse events.
Main Results:
- Low rates of intraocular inflammation (0.02%) and endophthalmitis (0.02%) per injection were observed.
- Conversion to nAMD occurred in 3.6% of at-risk eyes (4.3% annualized), with a higher rate in eyes with pre-existing nAMD.
- Visual acuity remained stable (+0.03 logMAR), and persistent ocular hypertension occurred in 1.0% of eyes, with no ischemic optic neuropathy or retinal vasculitis.
Conclusions:
- Avacincaptad pegol exhibits a favorable real-world ocular safety profile for GA secondary to AMD.
- Low incidences of inflammatory events, endophthalmitis, persistent ocular hypertension, and nAMD conversion support its clinical use.
- These findings offer valuable data for guiding clinical practice and patient management.
Related Concept Videos
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
